Boston, MA -- (SBWIRE) -- 09/02/2016 -- Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma. The global asthma therapeutics market will observe a moderate growth during the forecast period because of loss of patent exclusivity of the major drugs, allowing the entry of generics into the market. This will lead to the erosion of the market share of the major asthma drugs. However, the presence of late-stage pipeline molecules will drive the market. An increase in the prevalence of asthma and the use of combination drugs will drive the growth of the market during the forecast period.

Get More Details on this Report and a Full Table of Contents at Global Asthma Therapeutics Market 2016-2020

Technavio's analysts forecast the global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global asthma therapeutics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the sales of brand-name, generic, and off-label drugs used for the prevention and treatment of asthma. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from patent expiries of marketed drugs during the forecast period.

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Asthma Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-AstraZeneca
-Boehringer Ingelheim
-F. Hoffmann-La Roche
-GSK
-Merck

Other prominent vendors

-ALK-Abello
-Amgen
-Array BioPharma
-Asmacure
-Astellas Pharma
-Atopix Therapeutics
-Axikin Pharmaceuticals
-Chiesi Farmaceutici
-Dynavax Technologies Corp.
-Horizon Pharma
-Hovione Scientia
-Invion
-Ivax
-Kissei Pharmaceutical
-Kyowa Hakko Kirin
-MediciNova
-Mitsubishi Tanabe Pharma Corporation
-Mundipharma
-Nycomed
-Oxagen Limited
-Palobiofarma
-Pearl Therapeutics
-Pharmaking
-Pharmaxis
-Pulmagen Therapeutics
-Regeneron Pharmaceuticals
-Revalesio
-RSPR Pharma AB
-SAMA Pharmaceuticals
-Sanofi
-Skyepharma
-SolAeroMed
-Stallergenes
-Sterna Biologicals
-Synairgen
-Theron Pharmaceuticals
-UCB Pharma
-Vectura
-Verona Pharma
-Whanin Pharmaceutical Company

Market driver

-Huge market potential for mAbs
-For a full, detailed list, view our report

Market challenge

-Increased preference for CAM
-For a full, detailed list, view our report

Market trend

-Innovative technologies for drug delivery
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2020 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: AstraZeneca, , Boehringer Ingelheim, , F. Hoffmann-La Roche, , GSK, , Merck, , ALK-Abello, , Amgen, , Array BioPharma, , Asmacure, , Astellas Pharma, , Axikin Pharmaceuticals, , Chiesi Farmaceutici, , Dynavax Technologies, , Horizon Pharma, , Hovione Scientia, , Invion, , Ivax, , Kissei Pharmaceutical, , Kyowa Hakko Kirin, , MediciNova, , Mitsubishi Tanabe Pharma, , Mundipharma, , Nycomed, , Oxagen Limited, , Palobiofarma, , Pearl Therapeutics, , Pharmaking, , Pharmaxis, , Pulmagen Therapeutics, , Regeneron Pharmaceuticals, , Revalesio, , RSPR Pharma AB, , SAMA Pharmaceuticals, , Sanofi, , Skyepharma, , SolAeroMed, , Stallergenes, , Sterna Biologicals, , Synairgen, , Theron Pharmaceuticals, , UCB Pharma, , Vectura, , Verona Pharma, , Whanin Pharmaceutical.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Asthma Global Clinical Trials Review, H1, 2016
-Conjunctivitis Global Clinical Trials Review, H2, 2015
-Chronic Urticaria Or Hives Global Clinical Trials Review, H1, 2015
-Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2015
-Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market